"Clinical Ultrasound, a New Link Between Town and Hospital in Seine-Saint-Denis". (ECHO93)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
The ECHO93 study is a non-healthcare interventional study. Its aim is to evaluate the effect of introducing the echOpen probe into the management of patients referred to the Jean Verdier UDR, in terms of time to diagnosis.
The study is divided into 3 phases:
Phase 1: opening of the Rapid Diagnosis Unit (UDR) at Jean Verdier Hospital Phase 2: Opening of the Jean Verdier Hospital UDR, MSP Pantin, Dr TAYBALY's medical practice in Aulnay-sous-Bois, one month after the start of phase 1.
Phase 3: Opening of the Jean Verdier Hospital Health Bus, one month after the start of phase 2.
Eligibility criteria
Qualifiers
Adult patient over 18 years of age
Patient with signed informed consent
one of the structures involved (UDR/ SAU Jean Verdier, MSP Pantin, Cabinet Médical du Dr TAYBALY à Aulnay-sous-Bois) for referral to the UDR for rapid diagnosis (phases 1 and 2)
the Health Bus (phase 3)
Disqualifiers
Patient on the UDR iron-deficiency anemia clinical pathway
Patient deprived of liberty by judicial or administrative decision
Patient who does not speak French and cannot benefit from the presence of a relative or translator (physical or online)
patients with a body mass index greater than 34.9 kg/m2
Trial design
Treatments tested in this trial
- Echoscopy examination using the echOpen probe
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov